Dermatopathology
What they do most for Medicare patients
| Service, sort | Times billed, sort |
|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 2,530,560 |
| Destruction of precancer skin growth, 2-14 growths | 264,650 |
| Special stained specimen slides to examine tissue, initial procedure | 198,004 |
| Special stained specimen slides to examine tissue, each additional procedure | 184,266 |
| Special stained specimen slides to identify organisms including interpretation and report | 159,009 |
| Established patient office or other outpatient visit, 20-29 minutes | 90,026 |
| Pathology examination of tissue using a microscope, moderately low complexity | 74,757 |
| Destruction of precancer skin growth, 1 growth | 66,174 |
| Biopsy of related skin growth, first growth | 33,603 |
| Established patient office or other outpatient visit, 30-39 minutes | 33,315 |
| Destruction of skin growth, 1-14 growths | 25,949 |
| Special stained specimen slides to examine tissue including interpretation and report | 22,579 |
| Antibody evaluation, each additional single antibody stain procedure | 21,448 |
| Test for allergy using allergenic extract | 18,236 |
| Surgical pathology consultation and report on referred slides prepared elsewhere | 18,226 |
| Preparation of tissue for examination by removing any calcium present | 17,383 |
| Established patient office or other outpatient visit, 10-19 minutes | 17,009 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 16,983 |
| Detection test by nucleic acid for organism, amplified probe technique | 14,680 |
| Biopsy of related skin growth, each additional growth | 13,958 |
| Bacterial culture, any other source except urine, blood or stool, aerobic | 13,512 |
| Special gram or giemsa stain for microorganism | 13,434 |
| Bacterial culture for aerobic isolates | 12,179 |
| Bacterial culture, any source, except blood, anaerobic | 10,816 |
| New patient office or other outpatient visit, 30-44 minutes | 10,030 |
| Destruction of precancer skin growth, 15 or more growths | 7,946 |
| Test for allergy using skin patch | 7,905 |
| Pathology examination of specimen during surgery, first tissue block | 7,266 |
| Pathology examination of tissue using a microscope, moderately high complexity | 6,411 |
| Superficial and/or low voltage radiation treatment delivery | 5,787 |
| Antibody evaluation, initial single antibody stain procedure | 5,711 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 5,643 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 5,591 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 5,312 |
| Ultrasonic guidance for placement of radiation therapy fields | 5,306 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 4,838 |
| Surgical pathology consultation and report on referred material requiring preparation of slides | 4,632 |
| Testing for presence of drug, by chemistry analyzers | 4,132 |
| Blood test, comprehensive group of blood chemicals | 3,889 |
| New patient office or other outpatient visit, 45-59 minutes | 3,630 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 3,412 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 3,092 |
| Fungal culture (mold or yeast) of skin, hair, or nail | 2,611 |
| Microscopic genetic analysis of tumor, manual | 2,474 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 2,471 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 2,437 |
| Punch biopsy, first skin growth | 2,228 |
| Injection into skin growth, 1-7 growths | 2,193 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 2,176 |
| Destruction of skin growth, 15 or more growths | 2,069 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 1,900 |
| Cell examination of specimen, selective cellular enhancement technique | 1,895 |
| New patient office or other outpatient visit, 15-29 minutes | 1,832 |
| Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | 1,755 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,739 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 1,737 |
| Application of ultraviolet light to skin | 1,610 |
| Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 1,598 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,485 |
| Detection test for candida species (yeast), amplified probe technique | 1,318 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 1,285 |
| Biopsy of ear | 1,275 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 1,160 |
| Protein measurement, serum | 1,141 |
| Treatment of inflammatory skin disease using laser, less than 250.0 sq cm | 1,141 |
| Pathology examination of specimen during surgery, each additional tissue block | 1,135 |
| Insertion of needle into vein for collection of blood sample | 1,134 |
| Evaluation of fine needle aspirate with interpretation and report | 1,110 |
| Blood test, lipids (cholesterol and triglycerides) | 886 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 880 |
| Blood test, basic group of blood chemicals (calcium, total) | 877 |
| Pathology examination of tissue using a microscope, limited examination | 866 |
| Injection of drug or substance under skin or into muscle | 857 |
| Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | 827 |
| Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | 727 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 721 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 711 |
| Microscopic genetic analysis of nerve tissue | 688 |
| Immunologic analysis technique on serum (immunofixation) | 665 |
| Established patient office or other outpatient visit, 40-54 minutes | 656 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 648 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 636 |
| Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 629 |
| Digitization of glass microscope slides for level iv surgical pathology | 626 |
| Application of light with debridement to destroy precancer skin growth | 607 |
| Genetic sequencing localization, initial procedure | 599 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 594 |
| Culture for identification of yeast | 585 |
| Manual urinalysis test with examination using microscope, automated | 579 |
| Tissue preparation for culture | 569 |
| Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | 568 |
| Surgical pathology consultation and report, comprehensive | 527 |
| Identification of organisms by immunologic analysis, other than immunofluorescence method | 527 |
| Evaluation of fine needle aspirate | 515 |
| Pathology examination of tissue using a microscope | 505 |
| Simple or single drainage of skin abscess | 504 |
| Hemoglobin a1c level | 496 |
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 488 |
| Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | 485 |
| Blood test, clotting time | 485 |
Sources: Medicare Care Compare (hospitals and schools; Medicare-enrolled clinicians), CMS Medicare Physician & Other Practitioners 2023 (services), Medicare Part D Prescribers 2024 (drugs).